Inhibiting the Aurora B Kinase Potently Suppresses Repopulation During Fractionated Irradiation of Human Lung Cancer Cell Lines
Authors:
- Ali SakASAli Sak
- Martin StuschkeMSMartin Stuschke
- Michael GronebergMGMichael Groneberg
- Dennis KüblerDKDennis Kübler
- Christoph PöttgenCPChristoph Pöttgen
- Wilfried E.E. EberhardtWEWilfried E.E. Eberhardt
- 1 October 2012
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 84 (2) , 492-499
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Aurora kinase inhibitors in preclinical and clinical testingExpert Opinion on Investigational Drugs, 2009
- Deregulated Aurora‐B induced tetraploidy promotes tumorigenesisThe FASEB Journal, 2009
- Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instabilityBritish Journal of Cancer, 2005
- Repopulation of cancer cells during therapy: an important cause of treatment failureNature Reviews Cancer, 2005
- Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpointInternational Journal of Radiation Biology, 2002
- Mitotic kinases as regulators of cell division and its checkpointsNature Reviews Molecular Cell Biology, 2001
- Mutations of mitotic checkpoint genes in human cancersNature, 1998
- Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitroInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trialThe Lancet, 1997